Abstract

Recently,1 an attempt has been made to subdivide and classify the hallucinogens as follows:
  1. 1.

    Visionary psychodysleptics (e.g., LSD, mescaline, DMT). These produce prominently perceptual distortions and hallucinations, emotional changes, and changes in thinking.

     
  2. 2.

    Imagery-producing psychodysleptics (e.g., cannabis). These potentiate visual imagery and produce time, body-image, and thought distortion.

     
  3. 3.

    Trance-producing psychodysleptics [e.g., lysergic acid amide from Rivea corymbosa (ololiquhqui)].

     
  4. 4.

    Deliriants (e.g., atropine).

     
  5. 5.

    Neurotoxic psychodysleptics (e.g., lupenine) with an addition of motor, vegetative, and peripheral nervous system effects.

     

Keywords

Raphe Nucleus Ergot Alkaloid Plasma Prolactin Lateral Geniculate Body Methionine Adenosyltransferase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Diaz, J. L., 1967, Anna. Rev. Pharmacol. Toxicol. 17: 647–675.CrossRefGoogle Scholar
  2. 2.
    Brown, W. M., Keller, W. J., and Bonfiglio, J. F., 1979, Life Sci. 25: 1043–1054.CrossRefGoogle Scholar
  3. 3.
    Kantor, R. E., Dudletter. S. D., and Shulgin, A. T., 1980, Biol. Psychiatry 15: 349–352.PubMedGoogle Scholar
  4. 4.
    Brown, W. M., Keller, W. J., and Bonfiglio, J. F., 1978, Life Sci. 23: 1175–1184.CrossRefGoogle Scholar
  5. 5.
    Hempill, R. E., 1981, S. Afr. Med. J. 59: 96.Google Scholar
  6. 6.
    Aghajanian, G. K., Haigler, H. J., and Bloom, F. E., 1972, Life Sci. 11:615–622. 6a.de Montigny. C., and Aghajanian, G. K., 1977, Neuropharmacology 16: 811–818.Google Scholar
  7. 7.
    Briggs, I., 1977, J. Physiol. (Loud.) 265: 327–340.Google Scholar
  8. 8.
    Aghajanian, G. K., 1980, Brain Res. 186: 492–498.PubMedCrossRefGoogle Scholar
  9. 8a.
    a.Rogawski, M. A., and Aghajanian, G. K., 1979, Life Sci. 24: 1289–1298.Google Scholar
  10. 9.
    McCall, R. B., and Aghajanian, G. K., 1980, Life Sci. 26: 1149–1156.PubMedCrossRefGoogle Scholar
  11. 10.
    Geyer, M. A., 1978, Life Sci. 26: 431–434.CrossRefGoogle Scholar
  12. 11.
    Friedman, E., Lambert, G. A., and Buchweitz, E., 1978, Eur. J. Pharmacol. 49: 157–161.PubMedCrossRefGoogle Scholar
  13. 12.
    Hayes, R. L., Newton, P. G., Rosecrans, J. A., and Mayer, D. J., 1977, Brain Res. 122: 367–372.PubMedCrossRefGoogle Scholar
  14. 13.
    Lee, E. H. Y., and Geyer, M. A., 1980, Neuropharmacology 19: 1005–1007.PubMedCrossRefGoogle Scholar
  15. 14.
    Peters, D. A. V., and Tany, 1977, Biochem. Pharmacol. 26: 1085–1086.PubMedCrossRefGoogle Scholar
  16. 15.
    Marini, J. L., Jacobs, B. L., Sheard, M. H., and Trulson, M. E., 1981, Psychopharmacology 73: 328–331.PubMedCrossRefGoogle Scholar
  17. 16.
    Sloviter, R. S., Drust, E. G., Damiano, B. P., and Connor, J. D., 1980, J. Pharmacol. Exp. Ther. 214: 231–238.PubMedGoogle Scholar
  18. 17.
    Stroll, D. M., Gorelick, D. A., Bozewicz, T., Bridger, W. H., Gillin, J. C.. and Wyatt, R.. J., 1978, Psychopharmacologia 17: 1035–1040.Google Scholar
  19. 18.
    Smythies, J. R., Sykes, E. A., and Lord, C. P., 1966, Psychopharmacologia 9: 434–446.PubMedCrossRefGoogle Scholar
  20. 19.
    Winter, J. C., 1978, J. Pharmacol. Exp. Ther. 204: 416–423.PubMedGoogle Scholar
  21. 20.
    Glennon, R. A., Rosecrans, J. A., Young, R., and Gaines, J.. 1979, Life Sci. 24: 993–998.PubMedCrossRefGoogle Scholar
  22. 21.
    Kuhn, D. M., White, F. J., and Appel, J. B., 1978, Neuropharmacology 17: 257–263.PubMedCrossRefGoogle Scholar
  23. 22.
    Prozialeck, W. C., and Vogel, W. H., 1979, Psychopharmacology 60: 209–310.CrossRefGoogle Scholar
  24. 23.
    Colpaert, F. C., Niemegeers, C. J. E., and Janssen, P. A. J., 1979, Eur. J. Pharmacol. 58: 525–529.CrossRefGoogle Scholar
  25. 24.
    Fuxe, K., Agnati, L. F., Con-odi, H., Everitt, B. J., Hokfelt, T., Lofstrom, A., and Ungersteat, U., 1975, Adv. Neurol. 9: 223–242.Google Scholar
  26. 25.
    Menon, M. K., Clark, W. G., and Masuoka, D. T., 1977, Psychopharmacology 52: 291–297.PubMedCrossRefGoogle Scholar
  27. 26.
    Persson, S.-A., 1978, Life Sci. 23: 523–526.PubMedCrossRefGoogle Scholar
  28. 27.
    Persson, S.-A., and Johansson, H., 1978, Brain Res. 142: 505–513.PubMedCrossRefGoogle Scholar
  29. 28.
    Pieri, L., Keller, H. H., Burkard, W., and Da Prada, M., 1978, Nature 272: 278–279.PubMedCrossRefGoogle Scholar
  30. 29.
    Meltzer, H. Y., Fessier, R. G., Simonovic, M., Doherty, J., and Fang, V. S., 1977. Psycho-pharmacology 54: 39–44.CrossRefGoogle Scholar
  31. 30.
    Meltzer, H. Y., Fessier, R. G.. Simonovic, M., Doherty. J., and Fang, V. S., 1977, Psycho-pharmacology 54: 39–44.CrossRefGoogle Scholar
  32. 31.
    Meltzer, H. Y., Fessier, R. G., Simonovic, M., and Fang, V. S., 1978, Psychopharmacology 56: 255–259.PubMedCrossRefGoogle Scholar
  33. 32.
    Meltzer, H. Y., Fessier, R. G., Simonovic, M., and Fang, V. S., 1978, Life Sci. 23: 1185–1192.PubMedCrossRefGoogle Scholar
  34. Trulson, M. E., and Jacobs. B. L., 1979, Eur. J. Pharmacol. 54: 43–50.CrossRefGoogle Scholar
  35. 33.
    Fillion, G., Fillion, M. P., Jacob, J., and Rouselle, J. C., 1976, Br. J. Pharmacol. 58: 425P - 426 P.PubMedGoogle Scholar
  36. 34.
    Whittaker, P. M., and Seeman, P., 1978, Psychopharmacology 59: 1–5.CrossRefGoogle Scholar
  37. 35.
    Drummond, A. H., Bucher, F., and Levitan, I. B., 1970, J. Biol. Chem. 255: 6679–6686.Google Scholar
  38. 36.
    Drummond, A. H., Bucher, F., and Levitan, I. B., 1980, Brain Res. 184: 163–177.PubMedCrossRefGoogle Scholar
  39. 37.
    Trulson, M. E., and Jacobs, B. L., 1979, Life Sci. 24: 2053–2062.PubMedCrossRefGoogle Scholar
  40. 38.
    Glennon, R. A., Liebowitz, S. M., and Mack, E. C., 1978, J. Med. Chem. 21: 822–825.PubMedCrossRefGoogle Scholar
  41. 39.
    Gtennon, R. A., Liebowitz, S. M., and Anderson, G. M. III, 1980, J. Med. Chem. 23: 294–299.CrossRefGoogle Scholar
  42. 40.
    Glennon, R. A., Liebowitz, S. M., and Leming-Doot, D., 1980, J. Med. Chem. 23: 990–994.PubMedCrossRefGoogle Scholar
  43. 41.
    Burt, D. R., Creese, I., and Snyder, S. H., 1976, Mol. Pharmacol. 12: 631–638.PubMedGoogle Scholar
  44. 42.
    Drummond, A. H., Bucher, F., and Levitan, I. B., 1978, Nature 272: 368–370.PubMedCrossRefGoogle Scholar
  45. 43.
    Whittaker, P. M., and Seeman, P., 1977, J. Pharm. Pharmacol. 29: 506–507.CrossRefGoogle Scholar
  46. 44.
    Christoph, G. R.. Kuhn, D. M., and Jacobs, B. C., 1977, Life Sci. 21: 1585–1596.PubMedCrossRefGoogle Scholar
  47. 45.
    Christoph, G. R., Kuhn, D. M., and Jacobs, B. L., 1978, Life Sci. 23: 2099–2110.PubMedCrossRefGoogle Scholar
  48. 46.
    Creese, I., Burt, D. R., and Snyder, S. H., 1975, Life Sci. 17: 1715–1720.PubMedCrossRefGoogle Scholar
  49. 47.
    Ahn, H. S., and Makman, M. H., 1979, Brain Res. 162: 77–88.PubMedCrossRefGoogle Scholar
  50. 48.
    Nozaki, M., Vanpel, D. B., and Martin, W. R., 1977, Eur. J. Pharmacol. 46: 339–349.PubMedCrossRefGoogle Scholar
  51. 49.
    Rose, D., and Horn, G., 1977, Exp. Brain Res. 27: 71–80.PubMedCrossRefGoogle Scholar
  52. 50.
    Fox, P. C., and Dray, A., 1979, Brain Res. 161: 167–172.PubMedCrossRefGoogle Scholar
  53. 51.
    Dray, A., Fox, P. C., Hilary, M., and Somjer, G. G., 1980, Brain Res. 200: 105–121.PubMedCrossRefGoogle Scholar
  54. 52.
    Moore, R. H., Hatada, K., and Dommio, E. F., 1976, Neuropharmacology 15: 535–539.PubMedCrossRefGoogle Scholar
  55. 53.
    Trulson, M. E., and Jacobs, B. L., 1979, Science 205: 515–510.PubMedCrossRefGoogle Scholar
  56. 54.
    Whittaker, P. M., and Seeman, P., 1978, Proc. Natl. Acad. Sci. U.S.A. 75: 5783–5787.CrossRefGoogle Scholar
  57. 55.
    Dolphin, A., Enjalbert, A., Tassin, J.-P., Lucas, M., and Bockaert, J., 1978, Life Sci. 22:345352.Google Scholar
  58. 56.
    Frederickson, P. A., and Richelson, E., 1979, Eur. J. Pharmacol. 56: 261–264.Google Scholar
  59. 57.
    Hanbrich, D. R., and Wang, P. F. L., 1977, Brain Res. 131: 158–161.CrossRefGoogle Scholar
  60. 58.
    Wong, Y.-W., Chiu, S., and Mishra, R. K., 1979, Biochem. Pharmacol. 18: 2207–2209.Google Scholar
  61. 59.
    Fertziger, A. P., and Fischer, R., 1977, Psychopharmacology 54: 313–314.PubMedCrossRefGoogle Scholar
  62. 60.
    Commissaris, R. L., Moore, K. E., and Rech, R. H., 1980, Pharmacol. Biochem. Behay. 13: 601–607.CrossRefGoogle Scholar
  63. 61.
    Barker, S. A., Monti, J. A., and Christian, S. T., 1980, Biochem. Pharmacol. 29: 1049–1057.PubMedCrossRefGoogle Scholar
  64. 62.
    Stramentinoli, G., and Baldessarini, R. J.. 1978, J. Neurochem. 31: 1015–1020.PubMedCrossRefGoogle Scholar
  65. 63.
    Kelsoe, J. R., Tolbert, L. C., Crews, E. L., and Symthies, J. R., 1982, J. Neurosci. Res. 8: 99–103PubMedCrossRefGoogle Scholar
  66. 64.
    Sangiah, S., Gomez, M. V., and Domino, E. F., 1979, Biol. Psychiatry 14: 925–936.PubMedGoogle Scholar
  67. 65.
    Heikkila, J. J., Holbrook, L., and Brown, I. R., 1979, J. Neurochem. 32: 1793–1799.PubMedCrossRefGoogle Scholar
  68. 66.
    Holbrook, L., and Brown, I., 1977, Life Sci. 21: 1037–1044.PubMedCrossRefGoogle Scholar
  69. 67.
    Datta, R. K., Antopol, W., and Ghosh, J. J., 1971, Biochem. J. 125: 213–219.PubMedGoogle Scholar
  70. 68.
    Domelsmith, L. N., Munchangen, L. L., and Houk, K. N., 1977, J. Med. Chem. 20: 1346–1348.PubMedCrossRefGoogle Scholar
  71. 69.
    Glennon, R. A., and Gessner, P. K., 1977, Res. Commun. Chem. Pathol. Pharmacol. 18: 453–465.PubMedGoogle Scholar
  72. 70.
    Sissors, D. L., and Voss, E. W., Jr., 1978, Biochem. Pharmacol. 27: 2705–2711.PubMedCrossRefGoogle Scholar
  73. 71.
    Paul, S. M., Halaris, A. E., Freedman, D. X., and Hsu, L. L., 1976, J. Neurochem. 27: 625–627.PubMedCrossRefGoogle Scholar
  74. 72.
    Glennon, R. A., Schubert, E., Jacyno, J. M., and Rosecrans, J. A., 1980, J. Med. Chem. 23: 1222–1226.PubMedCrossRefGoogle Scholar
  75. 73.
    Vogel, W. H., and Evans, B. D., 1977, Life Sci. 20: 1629–1636.PubMedCrossRefGoogle Scholar
  76. 74.
    Symthies, J. R., Morin, R. D., and Brown, G. B., 1979, Biol. Psychiatry 14: 549–556.Google Scholar
  77. 75.
    Corbett, L., Christian, S. T., Benington, F., Smythies, J. R., and Morin, R. D., 1978, Br. J. Psychiatry 132: 139–144.PubMedCrossRefGoogle Scholar
  78. 76.
    Murray, R. M., Oon, M. C. H., Rodnight, R., Birley, J. L. T., and Smith, A., 1979, Arch. Gen. Psychiatry 36: 644–649.PubMedCrossRefGoogle Scholar
  79. 77.
    Haskovec, L., Jindrova, O., Krulik, R., and Paulovsky, P., 1981, Proceedings Illyd International Congress of Biological Psychiatry.Google Scholar
  80. 78.
    Checkley, S. A., Oon, M. C. H., Rodnight, R., Murphy, M. P., Williams, R. S., and Birley, J. L. T., 1979, Am. J. Psychiatry 136: 439–441.Google Scholar
  81. 79.
    Mehl, E., and Guiard, L., 1978, Hoppe Seylers Z. Physiol. Chem. 359: 539–541.PubMedGoogle Scholar
  82. 80.
    Barker, S. A., Harrison, R. E. W., Monti, J. A., Brown, G. B., and Christian, S. T., 1981, Biochem. Pharmacol. 30: 9–17.PubMedCrossRefGoogle Scholar
  83. 81.
    Rommelspacher, H., and Subramanian, N., 1979, Ear. J. Pharmacol. 56: 81–86.CrossRefGoogle Scholar
  84. 82.
    Bosin, T. R., and Beck, O., 1979, J. Neurochem. 32: 1853–1855.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • John R. Smythies
    • 1
  1. 1.Department of Psychiatry and Neurosciences ProgramUniversity of Alabama in BirminghamBirminghamUSA

Personalised recommendations